Craig Kelley

Zimmer Biomet Class I Recall of Shoulder Replacement Systems

The U.S. Food and Drug Administration (FDA) recognizes that a Class I recall has been issued on the  Zimmer Biomet Comprehensive Reverse Shoulder with a product description of Comprehensive Reverse Shoulder System Humeral Tray Model 115340 distributed between October of […]

Shezad Malik MD JD

Invokana Ketosis Side Effects leads to lawsuit

Invokana Ketosis Side Effects leads to lawsuit, filed in the federal court system claiming that side effects of Invokana caused a patient to develop severe dehydration and profound ketosis. Teresa Ross from Indiana, filed her product liability lawsuit in the […]

David Mittleman

Pharmaceutical Industry Creates OPIOID ADDICTION EPIDEMIC – Then Wants to Cure It?

Opioid addiction is the most recent medical condition that pharmaceutical companies have created and now claim they want to try to cure.  Americans use the most opioids of any nation; in 2013, 16,000 Americans died from overdosing on narcotic painkillers.  […]

Roopal Luhana

New Testosterone Studies: One Shows Increase of Plaque Build-Up

For the last few years, testosterone replacement drug manufacturers have been defending thousands of lawsuits filed by plaintiffs who took the drugs and then suffered from cardiovascular and venous thromboembolic events. Meanwhile, study results on the risks and benefits associated […]

Andrew D'Arcy


The side effects of a Mirena IUD caused a Pennsylvania woman to develop severe migraine headaches, blurred vision and a host of other health problems associated with the buildup of fluid pressure around her brain, according to allegations raised in […]

Craig Kelley

Breast Implants & Possible Anaplastic Large Cell Lymphoma

Back in 2011 the U.S. Food & Drug Administration (FDA) announced a possible link of breast implants to anaplastic large cell lymphoma (ALCL), which is a type of non-Hodgkin’s lymphoma.  Since that time, the World Health Organization has come out […]

Chad Finley

Deregulation and Budget Cuts Likely to Lead to Increased Adverse Event Reporting in Pharmaceutical Industry

With deregulation of FDA oversight, cuts in funding to institutions conducting government research and overview, and the potential for essentially the privatization of the FDA because of increased industry funding, it is likely we will see an increase in injuries and thus adverse event reports

Kendra Goldhirsch

Xarelto Manufacturers Eye New Patient Population as Lawsuits Continue

The anticoagulant drug Xarelto (rivaroxaban) is currently the subject of over 15,000 personal injury lawsuits pending in the Eastern District of Louisiana in a consolidated MDL litigation. Plaintiffs in these suits allege that after taking the drug, they suffered excessive […]

Shezad Malik MD JD

FDA Announces Heart Failure Warning for New Diabetic Medications

FDA announces Heart Failure Warning for new diabetic medications, Onglyza and Nesina. Type 2 diabetic patients are at increased risk of heart related complications from their disease and also suffer from life threatening side effects from the newer diabetic medications. […]

Chad Finley

Should I Report A Drug Injury or Drug Side Effect?

For all of these reasons, it is imperative that consumers understand that the need to report drug injuries or side effects is great. Reports are a critical way the FDA can detect injuries or side effects early and prevent it from unnecessarily happening to others